Cargando…

Clinical performance of different SARS‐CoV‐2 IgG antibody tests

Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) serological assays are urgently needed for rapid diagnosis, contact tracing, and for epidemiological studies. So far, there is limited data on how commercially available tests perform with real patient samples, and if positive tested sampl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kohmer, Niko, Westhaus, Sandra, Rühl, Cornelia, Ciesek, Sandra, Rabenau, Holger F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Short Communications
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7300776/ https://www.ncbi.nlm.nih.gov/pubmed/32510168 http://dx.doi.org/10.1002/jmv.26145

Ejemplares similares

Brief clinical evaluation of six high-throughput SARS-CoV-2 IgG antibody assays
por: Kohmer, Niko, et al.
Publicado: (2020)

Utility of Different Surrogate Enzyme-Linked Immunosorbent Assays (sELISAs) for Detection of SARS-CoV-2 Neutralizing Antibodies
por: Kohmer, Niko, et al.
Publicado: (2021)

The Comparative Clinical Performance of Four SARS-CoV-2 Rapid Antigen Tests and Their Correlation to Infectivity In Vitro
por: Kohmer, Niko, et al.
Publicado: (2021)

Suitability of Different Diagnostic Platforms for Virological Testing of Blood Samples from Cornea Donors
por: Kohmer, Niko, et al.
Publicado: (2022)

Comparative analysis of point-of-care, high-throughput and laboratory-developed SARS-CoV-2 nucleic acid amplification tests (NATs)
por: Kohmer, Niko, et al.
Publicado: (2021)

Assessment of SARS-CoV-2 Transmission on an International Flight and Among a Tourist Group
por: Hoehl, Sebastian, et al.
Publicado: (2020)

Evaluation of stability and inactivation methods of SARS-CoV-2 in context of laboratory settings
por: Widera, Marek, et al.
Publicado: (2021)

Riding the Omicron BA.5 Wave: Improved Humoral Response after Vaccination with Bivalent Omicron BA.4-5-Adapted mRNA SARS-CoV-2 Vaccine in Chronic Hemodialysis Patients
por: Ovcar, Eugen, et al.
Publicado: (2023)

SARS-CoV-2 Vaccination in Kidney Transplant Recipients—Stratified Analysis of the Humoral Immune Response
por: Lammert, Alexander, et al.
Publicado: (2022)

Diagnostic performance of an automated chemiluminescence immunoassay for SARS-CoV-2 IgG and IgM antibodies detection: A real life experience
por: Villalta, Danilo, et al.
Publicado: (2021)

Diagnosis of Acute Toxoplasmosis by IgG and IgM Antibodies and IgG Avidity in Pregnant Women from Mashhad, Eastern Iran
por: SHARIFI, Karam, et al.
Publicado: (2019)

A novel SARS-CoV-2 IgG line-blot for evaluating discrepant IgG test results – Observations in pre-pandemic and follow-up samples of five patients
por: Steiner, Andrea, et al.
Publicado: (2021)

SARS-CoV-2 IgG and IgA antibody response is gender dependent; and IgG antibodies rapidly decline early on
por: Korte, Wolfgang, et al.
Publicado: (2021)

Correlation between a quantitative anti‐SARS‐CoV‐2 IgG ELISA and neutralization activity
por: Dolscheid‐Pommerich, Ramona, et al.
Publicado: (2021)

Multiplex quantitative detection of SARS-CoV-2 specific IgG and IgM antibodies based on DNA-assisted nanopore sensing
por: Zhang, Zehui, et al.
Publicado: (2021)

Evaluation of Serologic Changes of IgG and IgM Antibodies Associated with SARS-COV-2 in Cancer Patients: A Cohort Seroprevalence Study
por: Arab, Maliheh, et al.
Publicado: (2021)

A luciferase immunosorbent assay for quantitative detection of IgG antibodies against SARS-CoV-2 nucleoprotein
por: Liang, Yuanhao, et al.
Publicado: (2021)

Presence of antibodies against SARS-CoV-2 spike protein in bovine whey IgG enriched fraction
por: Oshiro, Satoshi, et al.
Publicado: (2021)

Antibodies against spike protein of SARS-CoV-2 variants in bovine whey IgG enriched fraction
por: Oshiro, Satoshi, et al.
Publicado: (2022)

SARS-COV-2 IgG and IgM Antibodies in Cancer Patients
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2021)

Reply to Fabbris et al. A Viable Alternative. Comment on “Kohmer et al. Self-Collected Samples to Detect SARS-CoV-2: Direct Comparison of Saliva, Tongue Swab, Nasal Swab, Chewed Cotton Pads and Gargle Lavage. J. Clin. Med. 2021, 10, 5751”
por: Hoehl, Sebastian, et al.
Publicado: (2022)

Increasing but insufficient neutralizing activity against Omicron-BA.1 after a second booster dose of mRNA-1273 vaccine in chronic haemodialysis patients
por: Ovcar, Eugen, et al.
Publicado: (2022)

Comparison of a rapid immunochromatographic test with a chemiluminescence immunoassay for detection of anti-SARS-CoV-2 IgM and IgG
por: Gambino, Caterina Maria, et al.
Publicado: (2020)

IgG4/IgG RNA ratio does not accurately discriminate IgG4-related disease from pancreatobiliary cancer
por: de Vries, Elsemieke, et al.
Publicado: (2020)

SARS-CoV-2 IgG antibody responses in rt-PCR-positive cases: first report from India
por: Dash, Girish Chandra, et al.
Publicado: (2021)

Serologic Tests of IgG and IgM Antibodies and IgG Avidity for Diagnosis of Ocular Toxoplasmosis
por: Rahimi-Esboei, Bahman, et al.
Publicado: (2018)

Heterologous prime-boost immunization with ChAdOx1-S and BNT162b2: reactogenicity and immunogenicity in a prospective cohort study
por: Kohmer, Niko, et al.
Publicado: (2023)

Impact of different classes of immune-modulating treatments on B cell-related and T cell-related immune response before and after COVID-19 booster vaccination in patients with immune-mediated diseases and primary immunodeficiency: a cohort study
por: Koehm, Michaela, et al.
Publicado: (2023)

Diagnostic performance of the SARS-CoV-2 S1RBD IgG ELISA (ImmunoDiagnostics) for the quantitative detection of SARS-CoV-2 antibodies on dried blood spots
por: Meyers, Eline, et al.
Publicado: (2022)

Comparison of eight commercial, high-throughput, automated or ELISA assays detecting SARS-CoV-2 IgG or total antibody
por: Trabaud, Mary-Anne, et al.
Publicado: (2020)

Activation of SARS-CoV-2 neutralizing antibody is slower than elevation of spike-specific IgG, IgM, and nucleocapsid-specific IgG antibodies
por: Takahashi, Maika, et al.
Publicado: (2022)

Validation of rapid antibody (IgG-IgM) test kit for SARS-CoV-2 infection in Qatar
por: Mundodan, Jesha, et al.
Publicado: (2021)

Evaluation of 11 SARS-CoV-2 antibody tests by using samples from patients with defined IgG antibody titers
por: Lagerqvist, Nina, et al.
Publicado: (2021)

IgG antibody production and persistence to 6 months following SARS-CoV-2 vaccination: A Northern Ireland observational study
por: Robertson, Louise J., et al.
Publicado: (2022)

Prognostic Value of SARS-CoV-2 Anti-RBD IgG Antibody Quantitation on Clinical Outcomes in Hospitalized COVID-19 Patients
por: Madanat, Luai, et al.
Publicado: (2022)

SARS-COV-2 IgG antibody response in pregnant women at delivery
por: Tsatsaris, Vassilis, et al.
Publicado: (2021)

Long-Term Persistence of Anti-SARS-COV-2 IgG Antibodies
por: Yousefi, Zahra, et al.
Publicado: (2022)

IgG deposition in IgA nephropathy patients
por: Nasri, Hamid
Publicado: (2013)

Patients with Common Cold Coronaviruses Tested Negative for IgG Antibody to SARS-CoV-2
por: Brecher, Stephen M., et al.
Publicado: (2020)

Development of indigenous IgG ELISA for the detection of anti-SARS-CoV-2 IgG
por: Sapkal, Gajanan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_b4ha1admosr34t4v8fq4mh71jh